natgillin/translations-raw huggingface dataset:
A decision on whether to continue/discontinue breast-feeding or to continue/discontinue therapy with sevelamer carbonate should be made taking into account the benefit of breast-feeding to the child and the benefit of sevelamer carbonate therapy to the woman. 
Odluku o tome treba li nastaviti odnosno prekinuti dojenje ili nastaviti odnosno prekinuti liječenje sevelamerkarbonatom treba donijeti uzimajući u obzir korist dojenja za dijete i korist od liječenja sevelamerkarbonatom za majku.
The potential risk of Sevelamer carbonate Winthrop during human pregnancy is unknown. 
Mogući rizik uzimanja lijeka Sevelamer carbonate Winthrop tijekom trudnoće nije poznat.
• if you have problems with motility (movement) in your stomach and bowel 
• imate problema s motilitetom (pokretljivošću) želuca i crijeva
BSA (m2) 
Površina tijela (m2)
It can be used in patients undergoing haemodialysis (using a blood filtration machine) or peritoneal dialysis (where fluid is pumped into the abdomen and an internal body membrane filters the blood); 
Može se koristiti u bolesnika koji su podvrgnuti hemodijalizi (uz pomoć uređaja za filtraciju krvi) ili peritonejskoj dijalizi (kada se tekućina pumpa u trbušnu šupljinu, a unutarnja tjelesna membrana filtrira krv);
The recommended starting dose of this medicine for adults and elderly is one to two tablets of 800 mg with each meal, 3 times a day. 
Preporučena početna doza lijeka za odrasle i starije osobe je jedna do dvije tablete od 800 mg uz svaki obrok 3 puta na dan.
If you consider stopping your Sevelamer carbonate Winthrop treatment, contact your doctor or pharmacist first. 
Ako razmišljate o prestanku uzimanja lijeka Sevelamer carbonate Winthrop, obratite se najprije svom liječniku ili ljekarniku.
The sachet has to be discarded after 24 hours of opening. 
Vrećica se mora baciti 24 sata nakon otvaranja.
There are no or limited amount of data from the use of sevelamer in pregnant women. 
Nema podataka ili su podaci o primjeni sevelamera u trudnica ograničeni.
Take Sevelamer carbonate Winthrop after your meal or with food. 
Uzmite lijek Sevelamer carbonate Winthrop sa obrokom ili nakon obroka.
• Medicines treating heartburn and reflux from your stomach or oesophagus, such as omeprazole, pantoprazole, or lansoprazole, known as “proton pump inhibitors”, may reduce the efficacy of Sevelamer carbonate Winthrop. 
• Lijekovi za liječenje žgaravice i vraćanje kiseline iz želuca ili jednjaka, kao što su omeprazol, pantoprazol ili lanzoprazol, poznati i kao „inhibitori protonske pumpe“, mogu smanjiti djelotvornost lijeka Sevelamer carbonate Winthrop.
However the potential absorption and accumulation of sevelamer during long-term chronic treatment (> one year) cannot be totally excluded. 
Međutim, ne može se u potpunosti isključiti potencijal apsorpcije i akumulacije sevelamera tijekom dugotrajnog kroničnog liječenja (duljeg od godine dana).
Follow the diet prescribed by your doctor. 
Pridržavajte se dijete koju Vam je liječnik propisao.
A total of 101 patients (6 to 18 years old with a BSA range of 0.8 m2 to 2.4 m2) were randomised in the study. 
Ukupno je 101 bolesnik randomiziran za ispitivanje (u dobi od 6 do 18 godina s tjelesnom površinom u rasponu od 0,8 m2 do 2,4 m2).
If you have any further questions on the use of this medicine, ask your doctor or pharmacist. 
Ako imate daljnja pitanja o uporabi ovoga lijeka, obratite se svom liječniku ili ljekarniku.
• Sevelamer carbonate Winthrop should not be taken at the same time as ciprofloxacin (an antibiotic). 
• Sevelamer carbonate Winthrop se ne bi smio uzimati istodobno s ciprofloksacinom (antibiotik).
In rats and dogs, sevelamer reduced absorption of fat soluble vitamins D, E and K (coagulation factors), and folic acid. 
U štakora i pasa sevelamer je smanjio apsorpciju vitamina topivih u mastima - vitamina D, E i K (faktora koagulacije) i folatne kiseline.
If you do not take multivitamin supplements you may also develop low levels of vitamins A, E, K and folic acid in your blood and therefore your doctor may monitor these levels and prescribe supplemental vitamins as necessary. 
Ako ne uzimate multivitaminske dodatke prehrani, mogu se sniziti vrijednosti vitamina A, E i K te folatne kiseline u krvi te će ih stoga liječnik možda pratiti i po potrebi Vam propisati vitaminsku dopunu.
Children and adolescents (>6 years of age and a BSA of >0.75m2): 
Djeca/adolescenti (>6 godina starosti i površine tijela >0,75 m2)
Contents of the pack and other information What Sevelamer carbonate Winthrop contains 
Sadržaj pakiranja i druge informacije Što Sevelamer carbonate Winthrop sadrži
Your doctor should monitor the level of bicarbonate in your blood. 
Vaš liječnik bi trebao pratiti razinu bikarbonata u krvi.
Talk to your doctor before taking Sevelamer carbonate Winthrop : • if you have problems with motility (movement) in your stomach and bowel 
Obratite se svom liječniku prije nego što uzmete Sevelamer carbonate Winthrop ako: • imate problema s motilitetom (pokretljivošću) želuca i crijeva
• if you have active inflammation of the bowel • if you have undergone major surgery on your stomach or bowel. 
• imate aktivnu upalu crijeva • imali ste veliku operaciju želuca ili crijeva
For doses of less than 0.8 g, the powder in the sachet may be divided. 
Za doze manje od 0,8 g prašak u vrećici može se podijeliti.
For paediatric patients with a <1.2 BSA (m2), the oral suspension should be administered, as tablet formulations were not tested in this population and therefore are not appropriate for this population. 
Pedijatrijskim bolesnicima s površinom tijela <1,2 m2 treba biti primijenjena oralna suspenzija, budući da tablete nisu ispitane u ovoj populaciji i stoga nisu prikladne za ovu populaciju.
Additional treatments: Due to either your kidney condition or your dialysis treatment you may: 
Kao posljedicu bubrežne bolesti ili liječenja dijalizom možete:
The most serious adverse reactions are hypersensitivity (very rare frequency), intestinal obstruction (not known frequency), ileus/subileus (not known frequency), intestinal perforation (not known frequency), serious inflammatory gastrointestinal disorders associated with the presence of sevelamer crystals (not known frequency). 
Najozbiljnije nuspojave su preosjetljivost (vrlo rijetka učestalost), opstrukcija crijeva (nepoznata učestalost), ileus/subileus (nepoznata učestalost), perforacija crijeva (nepoznata učestalost) te ozbiljni gastrointestinalni upalni poremećaji povezani s prisutnošću kristala sevelamera (nepoznata učestalost).
For children, the powder is preferred, as tablets are not appropriate for this population. 
Za djecu se preporuča prašak jer tablete nisu prikladne za ovu populaciju.
Taking your Sevelamer carbonate Winthrop treatment is important to maintain an appropriate phosphate level in your blood. 
Uzimanje lijeka Sevelamer carbonate Winthrop je važno za održavanje odgovarajuće razine fosfata u krvi.
Each sachet of 0.8 g of powder is to be dispersed in 30 mL of water prior to administration (see section 6.6). 
Svaka vrećica od 0,8 g praška mora se prije primjene rastopiti u 30 ml vode (vidjeti dio 6.6).
Peritonitis is a known complication in patients receiving peritoneal dialysis and in a clinical trial with sevelamer hydrochloride, a greater number of peritonitis cases were reported in the sevelamer group than in the control group. 
Peritonitis je poznata komplikacija u bolesnika koji su na peritonejskoj dijalizi, a u kliničkom ispitivanju sevelamerklorida prijavljen je veći broj slučajeva peritonitisa u skupini liječenoj sevelamerkloridom nego u kontrolnoj skupini.
Initially, your doctor will check the levels of phosphorus in your blood every 2-4 weeks and may adjust the dose of Sevelamer carbonate Winthrop when necessary to reach an adequate phosphate level. 
Na početku liječenja, liječnik će Vam svaka 2-4 tjedna provjeravati razine fosfora u krvi te, bude li potrebno, može prilagoditi dozu lijeka Sevelamer carbonate Winthrop kako bi se postigle odgovarajuće razine fosfata.
He will base the dose on your serum phosphorus level. 
On će odrediti Vašu dozu na temelju razine fosfora u serumu.
• slow intestine motility (movement). 
• spori motilitet (pokretljivost) crijeva
Patients taking anti-arrhythmic medicinal products for the control of arrhythmias and anti-seizure medicinal products for the control of seizure disorders were excluded from clinical trials. 
Bolesnici koji uzimaju antiaritmike za kontrolu aritmija i lijekove protiv napadaja za kontrolu napadaja nisu bili uključeni u klinička ispitivanja, stoga se moguće smanjenje apsorpcije ne može isključiti.
- The other ingredients are microcrystalline cellulose, sodium chloride, zinc stearate, hypromellose (E464), diacetylated monoglycerides, iron oxide black (E172), isopropyl alcohol, propylene glycol and hypromellose (E464). 
- Drugi sastojci su mikrokristalična celuloza, natrijev klorid, cinkov stearat, hipromeloza (E464), diacetilirani monogliceridi, crni željezov oksid (E172), izopropilni alkohol i propilenglikol.
Paediatric dose based on BSA (m2) 
Pedijatrijska doza temeljena na površini tijela (m2) Površina tijela (m2)
The safety of sevelamer (as either carbonate and hydrochloride salts) has been investigated in numerous clinical trials involving a total of 969 haemodialysis patients with treatment duration of 4 to 50 weeks (724 patients treated with sevelamer hydrochloride and 245 with sevelamer carbonate), 97 peritoneal dialysis patients with treatment duration of 12 weeks (all treated with sevelamer hydrochloride) and 128 patients with CKD not on dialysis with treatment duration of 8 to 12 weeks (79 patients treatment with sevelamer hydrochloride and 49 with sevelamer carbonate). 
Sigurnost primjene sevelamera (u obliku karbonata ili klorida) ispitana je u brojnim kliničkim ispitivanjima s ukupno 969 bolesnika na hemodijalizi čije je liječenje trajalo od 4 do 50 tjedana (724 bolesnika liječena su sevelamerkloridom, a 245 sevelamerkarbonatom), 97 bolesnika na peritonejskoj dijalizi čije je liječenje trajalo 12 tjedana (svi su liječeni sevelamerkloridom) i 128 bolesnika s kroničnom bubrežnom bolešću koji nisu bili na dijalizi, čije je liječenje trajalo od 8 do 12 tjedana (79 bolesnika liječeno je sevelamerkloridom, a 49 sevelamerkarbonatom).
Do not heat Sevelamer carbonate Winthrop powder (e.g. microwave) or add to hot foods or liquids. 
Nemojte zagrijavati Sevelamer carbonate Winthrop prašak (npr. u mikrovalnoj pećnici) niti ga dodavati u vruću hranu ili tekućine.
For patients previously on phosphate binders (sevelamer hydrochloride or calcium based), Sevelamer carbonate Winthrop should be given on a gram for gram basis with monitoring of serum phosphorus levels to ensure optimal daily doses. 
Bolesnicima koji su prethodno uzimali vezače fosfata (sevelamerklorid ili vezače fosfata na bazi kalcija) Sevelamer carbonate Winthrop se mora davati gram za gram, uz praćenje razina fosfora u serumu kako bi se osigurala primjena optimalnih dnevnih doza.
It is unknown whether Sevelamer carbonate Winthrop is excreted in breast milk and may affect your baby. 
Nije poznato izlučuje li se Seevelamer carbonate Winthrop u majčino mlijeko i utječe li na dijete.
Each sachet of 2.4 g of powder is to be dispersed in 60 ml of water prior to administration (see section 6.6). 
Svaka vrećica od 2,4 g praška mora se prije primjene rastopiti u 60 ml vode (vidjeti dio 6.6).
The most frequently occurring (≥5% of patients) adverse reactions were all in the gastrointestinal disorders system organ class: nausea (very common), vomiting (very common), upper abdominal pain (very common), constipation (very common), diarrhea (common), dyspepsia (common) and flatulence (common). 
Sve najčešće nuspojave (≥ 5% bolesnika) pripadale su u poremećaje probavnog sustava: mučnina (vrlo često), povraćanje (vrlo često), bol u gornjem dijelu abdomena (vrlo često), konstipacija (vrlo često), proljev (često), dispepsija (često) i flatulencija (često).
Constipation can be an early symptom of serious gastrointestinal adverse reactions. 
Konstipacija može biti rani simptom ozbiljnih gastrointestinalnih nuspojava.
In patients undergoing peritoneal dialysis additional monitoring of fat-soluble vitamins and folic acid is recommended, since vitamin A, D, E and K levels were not measured in a clinical study in these patients. 
U bolesnika na peritonejskoj dijalizi preporučuje se dodatno praćenje razine vitamina topivih u mastima i folatne kiseline, jer se u kliničkom ispitivanju u tih bolesnika nisu mjerile vrijednosti vitamina A, D, E i K.
Sevelamer carbonate Winthrop powder should not be heated (e.g. microwave) or added to heated foods or liquids. 
Sevelamer carbonate Winthrop prašak se ne smije zagrijavati (npr. u mikrovalnoj pećnici) niti dodavati u zagrijanu hranu ili tekućine.
o Hold the dosing spoon horizontally and pour the powder out of the sachet into the dosing spoon. 
o Držite dozirnu žličicu horizontalno i istresite prašak iz vrećice u dozirnu žličicu.
Serum calcium levels should therefore be monitored at regular intervals and elemental calcium should be given as a supplement if required. 
Potrebno je u redovitim intervalima nadzirati razine kalcija u serumu te po potrebi davati dopunu elementarnog kalcija.
Do not use this medicine after the expiry date stated on the bottle and/or carton after “EXP”. 
Ovaj lijek se ne smije upotrijebiti nakon isteka roka valjanosti navedenog na bočici i/ili kutiji iza oznake „EXP”.
o Do not tap the dosing spoon to compact the powder. 
. o Ne tapkajte žličicu za doziranje kako biste istisnuli prašak.
Studies in animals have shown that sevelamer did not impair fertility in male or female rats at exposures at a human equivalent dose 2 times the maximum clinical trial dose of 13 g/day, based on a comparison of relative BSA. 
Ispitivanja na životinjama pokazala su da sevelamer nije štetno utjecao na plodnost mužjaka ili ženki štakora pri ekspoziciji dozama koje na temelju usporedbe relativne tjelesne površine odgovaraju dvostrukoj maksimalnoj dozi za ljude u kliničkim ispitivanjima od 13 g/dan.
These symptoms can be due to serious inflammatory bowel disease caused by sevelamer crystal deposit in your bowel. 
Ovi se simptomi mogu javiti zbog ozbiljne upalne bolesti crijeva, koju uzrokuje nakupljanje kristala sevelamerkarbonata u crijevima.
Your doctor may monitor the phosphate level in your blood. 
Liječnik će možda pratiti razinu fosfata u krvi.
Sevelamer carbonate Winthrop is unlikely to affect your ability to drive or to use machines. 
Nije vjerojatno da će Sevelamer carbonate Winthrop utjecati na sposobnost upravljanja vozilima i strojevima.
Reduced levels of ciclosporin, mycophenolate mofetil and tacrolimus have been reported in transplant patients when co-administered with sevelamer hydrochloride without any clinical consequences (e.g., graft rejection). 
Ciklosporin, mofetilmikofenolat i takrolimus u transplantiranih bolesnika Zabilježene su snižene vrijednosti ciklosporina, mofetilmikofenolata i takrolimusa u transplantiranih bolesnika kod istodobne primjene sevelamerklorida, bez kliničkih posljedica (npr. odbacivanja presatka).
• if you have undergone major surgery on your stomach or bowel. 
• imali ste veliku operaciju želuca ili crijeva
Interaction studies have not been conducted in patients on dialysis. 
Dijaliza Nisu provedena ispitivanja interakcija u bolesnika na dijalizi.
What Sevelamer carbonate Winthrop looks like and contents of the pack 
Kako Sevelamer carbonate Winthrop izgleda i sadržaj pakiranja
PARTICULARS TO APPEAR ON THE OUTER PACKAGING OUTER CARTON - BOTTLE OF 30 TABLETS 
PODACI KOJI SE MORAJU NALAZITI NA VANJSKOM PAKIRANJU VANJSKA KUTIJA - BOČICA S 30 TABLETA
What Sevelamer carbonate Winthrop is and what it is used for 
Što je Sevelamer carbonate Winthrop i za što se koristi
The tablets are packed in high density polyethylene bottles with a child-resistant polypropylene closure and an induction seal. 
Tablete su pakirane u bočice od polietilena visoke gustoće s polipropilenskim sigurnosnim zatvaračem za djecu i zalijepljenom zaštitnom folijom.
Sevelamer carbonate Winthrop powder for oral suspension is a pale yellow powder supplied in a foil sachet with a heat seal. 
Sevelamer carbonate Winthrop prašak za oralnu suspenziju je blijedožuti prašak koji se nalazi u toplinski zalijepljenoj vrećici od folije.
Use the provided dosing spoon for each 0.4 g dose of Sevelamer Carbonate Winthrop powder. 
Koristite u pakiranju priloženu dozirnu žličicu za svaku dozu od 0,4 g Sevelamer carbonate Winthrop praška.
Patients who are constipated should be monitored carefully while being treated with sevelamer carbonate. 
Bolesnike koji pate od konstipacije treba pomno nadzirati tijekom liječenja sevelamerkarbonatom.
Your doctor can rather prescribe sevelamer carbonate powder for oral suspension. 
Vaš liječnik vam može propisati Sevelamer carbonate Winthrop prašak za oralnu suspenziju.
Iron oxide black (E172) Propylene glycol Isopropyl alcohol Hypromellose (E464) 
željezov oksid, crni (E172) propilenglikol izopropilni alkohol hipromeloza (E464)
Frequency is not known. 
Učestalost je nepoznata.
Proper swallowing ability should be carefully monitored in patients with co-morbid conditions. 
Sposobnost normalnog gutanja mora se pomno pratiti u bolesnika s popratnim bolestima.
PARTICULARS TO APPEAR ON THE IMMEDIATE PACKAGING LABEL - BOTTLE OF 180 TABLETS WITHOUT OUTER CARTON 
PODACI KOJI SE MORAJU NALAZITI NA UNUTARNJEM PAKIRANJU NALJEPNICA - BOČICA SA 180 TABLETA (BEZ VANJSKE KUTIJE)
Packs of 1 bottle of 30 tablets or bottles of 180 tablets without outer carton. 
Pakiranje od 1 bočice s 30 tableta ili bočice sa 180 tableta, bez vanjske kutije.
It may harm them, even if their signs of illness are the same as yours. 
- puknuće stijenke crijeva (znakovi uključuju: jaku bol u trbuhu, zimicu, vrućicu, mučninu, povraćanje i osjetljivost trbuha) je prijavljeno.
Preparation using a dosing spoon: 
Priprema uporabom dozirne žličice
The possibility of an interaction cannot be excluded and a close monitoring of blood concentrations of ciclosporin, mycophenolate mofetil and tacrolimus should be considered during the use of combination and after its withdrawal. 
Ne može se isključiti mogućnost interakcije te treba razmotriti pozorno praćenje koncentracija ciklosporina, mofetilmikofenolata i takrolimusa u krvi tijekom i nakon kombinirane primjene s lijekom Sevelamer carbonate Winthrop.
Intestinal obstruction, Ileus/subileus, Intestinal perforation1, Gastrointestinal hemorrhage1, Intestinal ulceration1, Gastrointestinal necrosis1, Colitis1, Intestinal mass1 
Poremećaji probavnog sustava mučnina, povraćanje, bol u gornjem dijelu abdomena, konstipacija proljev, dispepsija, flatulencija, bol u abdomenu opstrukcija crijeva, ileus/subileus, perforacija crijeva1, gastrointestinalna hemoragija1, ulceracija crijeva1, gastrointestinalna nekroza1, kolitis1, masa u crijevima1
Sevelamer carbonate Winthrop must be taken three times per day with meals or snacks. 
Sevelemer carbonate Winthrop se mora uzimati tri puta dnevno s obrocima ili međuobrocima.
EU/1/14/952/001 180 film-coated tablets 
EU/1/14/952/001 180 filmom obloženih tableta
Each film-coated tablet contains 800 mg of sevelamer carbonate. 
Jedna filmom obložena tableta sadrži 800 mg sevelamerkarbonata.
In this case the 0.4 g dose of Sevelamer Carbonate Winthrop powder must be measured using the dosing spoon provided in the carton. 
U tom slučaju doza od 0,4 g Sevelamer carbonate Winthrop praška mora se odmjeriti uporabom dozirne žličice koja je priložena u kutiji.
• Hypophosphataemia. 
• Hipofosfatemija
Sevelamer carbonate Winthrop is indicated for the control of hyperphosphataemia in paediatric patients (>6 years of age and a body surface area (BSA) of >0.75 m2) with chronic kidney disease. 
Sevelamer carbonate Winthrop je indiciran za kontrolu hiperfosfatemije u pedijatrijskih bolesnika (>6 godina starosti i površine tijela >0,75 m2) s kroničkom bubrežnom bolesti.
HDPE bottles with a child resistant polypropylene closure and a foil induction seal. 
HDPE bočice s polipropilenskim sigurnosnim zatvaračem za djecu i zalijepljenom zaštitnom folijom.
The phosphate serum level should be monitored and the sevelamer carbonate dosage adjusted consequently. 
Potrebno je pratiti razinu fosfata u serumu i posljedično prilagoditi dozu sevelamerkarbonata.
60 sachets per carton 90 sachets per carton 
60 vrećica u kutiji 90 vrećica u kutiji
If you take more Sevelamer carbonate Winthrop than you should 
Ako uzmete više lijeka Sevelamer carbonate Winthrop nego što ste trebali
• have disturbed level of bicarbonate in your blood and increased acidity in the blood and other body tissue. 
• imati poremećenu razinu bikarbonata u krvi te povišenu kiselost u krvi i drugih tjelesnih tkiva.
Carcinogenicity studies with oral sevelamer hydrochloride were conducted in mice (doses of up to 9 g/kg/day) and rats (0.3, 1, or 3 g/kg/day). 
9 g/kg/dan) i štakorima (0,3, 1 ili 3 g/kg/dan).
Patients taking sevelamer carbonate should adhere to their prescribed diets. 
Bolesnici koji uzimaju sevelamerkarbonat moraju se pridržavati propisanog načina prehrane.
(Instructions for presentation with dosing spoon) The sachet has to be discarded after 24 hours of opening 
(Upute za pakiranje sa dozirnom žličicom) Vrećica se mora baciti nakon 24 sata od otvaranja.
The anti-arrhythmic medical product should be taken at least one hour before or three hours after Sevelamer carbonate Winthrop, and blood monitoring can be considered. 
Lijekove protiv aritmije potrebno je uzeti barem jedan sat prije ili tri sata nakon uzimanja lijeka Sevelemar carbonate Winthrop te se može razmotriti praćenje koncentracije u krvi.
Other medicines and Sevelamer carbonate Winthrop 
Drugi lijekovi i Sevelamer carbonate Winthrop
Crystal deposit intestine1 
Pretrage kristalne naslage u crijevu1
Patients taking Sevelamer carbonate Winthrop should adhere to their prescribed diets. 
Bolesnici koji uzimaju Sevelamer carbonate Winthrop moraju se pridržavati propisanog načina prehrane.
The recommended starting dose of sevelamer carbonate is 2.4 g or 4.8 g per day based on clinical needs and serum phosphorus level. 
Početna doza Preporučena početna doza sevelamerkarbonata je 2,4 g ili 4,8 g na dan, ovisno o kliničkim potrebama i razini fosfora u serumu.
Sevelamer carbonate Winthrop must be taken three times per day with meals. 
Sevelamer carbonate Winthrop mora se uzimati triput na dan uz obrok.
EU/1/14/952/004 30 film-coated tablets 
EU/1/14/952/004 30 filmom obloženih tableta
• cases of itching, 
• slučajevi svrbeža,
Sevelamer hydrochloride, which contains the same active moiety as sevelamer carbonate, has been given to normal healthy volunteers in doses of up to 14 grams per day for eight days with no adverse reaction. 
Sevelamerklorid, koji sadrži istu djelatnu tvar kao sevelamerkarbonat, bio je davan zdravim dobrovoljcima u dozama do 14 grama na dan tijekom osam dana bez razvoja nuspojava.
To achieve the correct dose when the sachet has to be divided, please use the dedicated presentation of 0.8 g powder with dosing spoon. 
Kako bi se postigla ispravna doza kada se vrećica s praškom mora podijeliti, koristiti za to predviđeno pakiranje s vrećicama od 0,8 g praška s priloženom dozirnom žličicom.
Sevelamer carbonate Winthrop is indicated for the control of hyperphosphataemia in adult patients receiving haemodialysis or peritoneal dialysis. 
Sevelamer carbonate Winthrop je indiciran za kontrolu hiperfosfatemije u odraslih bolesnika koji su na hemodijalizi ili peritonejskoj dijalizi.
The study met its primary endpoint, meaning sevelamer carbonate reduced serum phosphorus by an LS mean difference of 0.90 mg/dL compared to placebo, and secondary efficacy endpoints. 
Ispitivanje je postiglo mjeru primarnog ishoda, što znači da je sevelamerkarbonat smanjio razinu fosfora u serumu za srednju vrijednost (dobivenu metodom najmanjih kvadrata) razlike od 0,90mg/dL u usporedbi s placebom, i mjere sekundarnih ishoda djelotvornosti.
Each carton contains 90 sachets and a dosing spoon to measure the 0.4 g dose of powder. 
(Upute za pakiranje sa dozirnom žličicom) Jedna kutija sadrži 90 vrećica i dozirnu žličicu za odmjeravanje doze od 0,4 g praška.